NOTCHing down a win for megakaryocytes

Citations of this article
Mendeley users who have this article in their library.


By exploiting a congenic pair of induced pluripotent stem cell (iPSC) lines derived from a familial platelet disorder (FPD) patient, 1 harboring a mono-allelic mutation in RUNX1 and the other a corrected allele, in this issue of Blood, Li et al have discovered that negative regulation of NOTCH4 by RUNX1 is required for normal human megakaryocyte (MK) development. Furthermore, the authors demonstrate that suppressing NOTCH signaling, by either genetic or chemical perturbation, significantly enhances MK yield. 1




Taoud, S. (2018, January 11). NOTCHing down a win for megakaryocytes. Blood. American Society of Hematology.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free